Clinical Trials Logo

Clinical Trial Summary

Endovascular aneurysm repair (EVAR) was introduced in 1990 for the first time as a minimally invasive procedure instead of the conventional open surgical repair, with the aim to decrease morbidity and mortality . Nowadays EVAR has become an acceptable management for patients with infra-renal aortic aneurysms (AAA) . A lot of anesthetic techniques have been used successfully for EVAR. EVAR requires sedative analgesic medications to achieve an acceptable level of comfort to the patient and cardiorespiratory stability.

This is prospective randomized single blinded study of patients presenting with aorto-iliac aneurysm who will undergo EVAR. Patient's demographic data will be assessed, as well as clinical presentation, intraoperative complications.

30 patients undergoing elective EVAR will be included and will be divided equally into 2 groups.

First group is the psoas compartment block (PCB) (15 patients): 30 ml of bupivacaine 0.25% will be infused over 3 minutes at the anatomical landmark.

Second group is the LA and remifentanil group (LR) (15 patients): lidocaine 5 ml of 2% will be injected subcutaneous as local infiltration then remifentanil infusion with rate 0.03-0.1 μg kg−1 min−1. to achieve visual analog scale (VAS) 3 or less.

Vital date will be recorded as baseline then every 5 minutes till the end of the procedure. VAS will be recorded as baseline then every 5 minutes till the end of the procedure. Also stress response which will be measured subjectively as vital data and VAS and objectively as cortisol level in the blood which will be measured as base line and immediate after the end of the procedure.


Clinical Trial Description

Anatomical, imaging and clinical studies suggest that psoas compartment block (PCB) which was done at L2-L3 level has a high possibility to include L1-L2 roots, and thus can be suitable for inguinal surgery. In our study, the investigators introduce a modified PCB which will be performed in lateral decubitus by a 120 mm stimulated needle inserted at the junction between the lateral third and the medial two-thirds of a line drawn at L2-L3 interspace, between the interspinous line and a line passing through the posterior superior iliac spine (PSIS), parallel to the interspinous line . If twitching of the anterior thigh area is observed, the needle is moved slight cranially. When twitching of the inguinal field is observed, bupivacaine 0.5% 30 ml, will be injected ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03443518
Study type Interventional
Source Dr. Erfan and Bagedo General Hospital
Contact
Status Completed
Phase Phase 2
Start date February 6, 2018
Completion date December 10, 2018

See also
  Status Clinical Trial Phase
Recruiting NCT03453541 - Ketorolac Use in Pediatric Patients Undergoing Tonsillectomy Phase 4
Completed NCT05880433 - The Effects of Mydriatic Eye Drops in Retinopathy of Prematurity Examinations
Recruiting NCT04369222 - The Copenhagen Analgesic Study
Completed NCT03493490 - Neodolpasse® Infusion Solution Versus Diclofenac 75 mg Infusion in the Treatment of Postoperative Pain After Elective Knee Surgery Phase 4
Recruiting NCT05924412 - Parecoxib in Total Knee Arthroplasty Phase 4
Completed NCT03203967 - Epidural Morphine for Postoperative Analgesia After Total Knee Arthroplasty N/A
Completed NCT03841812 - Comparation Analgesia Efficiency With Propofol Combine Sevoflurane vs Propofol Phase 3
Completed NCT02717637 - Oxycodone in Serum After Postoperative Oral Oxycodone in Caesarean Sections Under Spinal Anesthesia N/A
Completed NCT03665792 - The Correlation Between Sevoflurane and qNOX
Completed NCT04226443 - The Use of Midazolam and Remifentanil During Dialysis Access Procedures N/A
Recruiting NCT05575700 - Safety of Ibuprofen After Major Orthopaedic Surgeries Phase 4